In addition, bixin and norbixin increased antioxidant enzymes activity in animal models of diabetes and atherosclerosis [17, 18], while bixin upregulated gene expression of SOD and CAT in a mouse model of diabetic cardiomyopathy [66]. The gene discussed is CAT; the disease is diabetes mellitus.